Product Description: YM-90709 is a novel IL-5 inhibitor which selectively blocks the binding of IL-5 to the IL-5 receptor (IL-5R).YM-90709 potently inhibits the binding of [125I]-IL-5 to IL-5R on human peripheral eosinophils and eosinophilic HL-60 clone 15 cells with IC50 values of 1.0 and 0.57 μM[1].
Applications: COVID-19-immunoregulation
Formula: C22H21N3O2
References: [1]Morokata T, et al. Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor. Int Immunopharmacol. 2002 Nov;2(12):1693-702./[2]Morokata T, et al. Effect of a novel interleukin-5 receptor antagonist, YM-90709, on antigen-induced eosinophil infiltration into the airway of BDF1 mice. Immunol Lett. 2005 Apr 15;98(1):161-5.
CAS Number: 163769-88-8
Molecular Weight: 359.42
Compound Purity: 99.77
Research Area: Inflammation/Immunology
Solubility: DMSO : 62.5 mg/mL (ultrasonic)
Target: Interleukin Related
Deutsch
English
